Skip to content
GenoLensGenoLens

ADNP

Chr 20q13.13

activity dependent neuroprotector homeobox

Aliases:
KIAA0784, ADNP1
MANE:
ENST00000621696.5

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Clefting

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder

    0.78
  • ADNP-related multiple congenital anomalies-intellectual disability-autism spectrum disorder

    0.74
  • hereditary disease

    0.55
  • Intellectual disability

    0.53
  • neurodegenerative disease

    0.49
  • prostate carcinoma

    0.41
  • Global developmental delay

    0.35
  • neurodevelopmental disorder

    0.35
  • Seizure

    0.29
  • autism spectrum disorder

    0.28

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Activity-dependent neuroprotector homeobox protein

May be involved in transcriptional regulation. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation. Positively modulates WNT-beta-catenin/CTNN1B signaling, acting by regulating phosphorylation of, and thereby stabilizing, CTNNB1. May be required for neural induction and neuronal differentiation. May be involved in erythroid differentiation (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.